Tower (TSEM) Q4 2025 earnings review
Record Revenue Meets Strategic Shock
Tower delivered a breakout quarter with record revenue of $440M (+14% YoY) and a surge in profitability, validating its pivot to AI-driven optical/SiPho markets. Margins expanded significantly as the company hit its 'acceleration' target for H2. However, a major strategic blow arrived alongside the numbers: Intel has reneged on the New Mexico capacity corridor agreement, forcing Tower to redirect production back to Japan and enter mediation. While operational execution is flawless, the capacity roadmap has suddenly become complicated.
🐂 Bull Case
Operational leverage kicked in hard. Q4 Gross Margin jumped to 26.7% (from 23.5% in Q3) and Net Profit surged 48% QoQ to $80M. The shift to higher-value SiPho/SiGe products is materially impacting the bottom line.
Management doubled down on its strongest driver, announcing an *additional* $270M CapEx for SiPho (totaling $920M). They target 5x capacity expansion by late 2026, signaling immense committed demand from hyperscalers for optical transceivers (1.6T).
🐻 Bear Case
Intel's decision to void the New Mexico capacity agreement is a significant disruption. Flows intended for US manufacturing must revert to Fab 7 (Japan), which was already reporting >85% utilization. This creates immediate capacity constraint risks.
Free Cash Flow turned deeply negative. Operating cash flow was just $40M (hit by a $105M lease prepayment) against $111M in CapEx. With another $270M investment announced, Tower is entering a period of intense capital consumption.
⚖️ Verdict: 🟢
Bullish. The Intel news is a logistical headache, but the financials are undeniable. Tower is successfully riding the AI infrastructure wave, delivering record revenues and expanding margins. The massive new CapEx commitment suggests the order book for 2026-2027 is stronger than the market realizes.
Key Themes
Intel Manufacturing Agreement Terminated
In a shock disclosure, Tower revealed Intel 'does not intend to perform' under the 2023 New Mexico capacity agreement. Tower is now in mediation and redirecting flows back to Fab 7 in Japan. This unravels a key part of the post-merger-termination strategy and risks squeezing capacity in Japan.
SiPho/SiGe Capacity Aggression
Tower is 'all in' on Silicon Photonics. Citing 'surging demand' for 1.6T transceivers, they added $270M to the SiPho CapEx budget, bringing the total to $920M. The target is to have >5x the current capacity qualified by Q4 2026. This confirms Tower is a primary pick-and-shovel play for AI data center interconnects.
Operational Leverage Realized
The Q4 results demonstrated powerful leverage. While revenue grew 11% QoQ, Operating Profit grew 39% ($51M to $71M). The high-margin nature of the new RF Infrastructure mix is finally showing up in the P&L.
Lease and Litigation Headwinds
Operational cash flow was hit by a $105M prepayment for the Fab 3 lease extension. Additionally, the landlord is suing for a 'material non-curable breach' regarding noise abatement. Combined with the Intel mediation, legal distractions and costs are mounting.
Fab 1 Consolidation Complete
The discontinuation of lower-margin 150mm legacy flows in Fab 1 (Israel) is largely complete, with flows moved to Fab 2. This consolidation likely contributed to the gross margin improvement seen in Q4.
Other KPIs
Accelerating. A major jump from 23.5% in Q3 and 22.4% a year ago. This reflects the improved product mix (SiPho) and higher utilization, despite the new lease costs.
Accelerating. Up 45% YoY and 49% QoQ. EPS of $0.71 beat the $0.48 seen in Q3. The company is generating significant earnings power despite heavy investment phases.
Reversing. Operating Cash Flow ($40M) failed to cover CapEx ($111M). The OCF was weighed down by the $105M lease payment. Adjusted for that one-off, OCF would be ~$145M, implying underlying positive FCF, but reported cash burn is real.
Guidance
Accelerating YoY. While sequentially down 6% (typical seasonality), this represents 15% YoY growth, an acceleration from the 9% YoY growth seen in 25Q1. It confirms the growth trajectory remains intact despite the Intel setback.
Key Questions
Intel Capacity Contingency
With Intel reneging on the NM corridor and Fab 7 utilization already high (>85% in Q3), where specifically will the displaced wafers go, and will this constrain revenue growth in 2026?
SiPho 5x Demand Verification
You are committing nearly $1B in CapEx for SiPho. Are these investments backed by non-cancellable orders or take-or-pay contracts, specifically to avoid an 'Intel situation' with these new customers?
Fab 3 Litigation Risk
The Fab 3 landlord is seeking a declaration of 'material non-curable breach.' What is the worst-case scenario here—eviction? And why prepay $105M in rent amidst an active eviction threat?